Extracellular vesicles from Trypanosoma cruzi-dendritic cell interaction show modulatory properties and confer

Brenda Celeste Gutierrez1, Maria Eugenia Ancarola1, Izadora Volpato-Rossi2,3

  • 1Instituto de Investigaciones en Microbiología y Parasitología Médicas (IMPaM), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Insights

Extracellular vesicles (EVs) released during Trypanosoma cruzi infection of dendritic cells (DCs) can protect against lethal infection. These parasite-modified EVs may hold therapeutic potential for Chagas disease.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Extracellular vesicles (EVs) mediate intercellular communication and play roles in immune responses.
  • Trypanosoma cruzi (T. cruzi) parasites modulate dendritic cell (DC) immunogenicity.
  • EVs are shed by various pathogens, including T. cruzi.

Purpose of the Study:

  • To investigate the molecular characterization of EVs generated from the in vitro interaction between T. cruzi trypomastigotes (Tp) and bone-marrow-derived DCs.
  • To identify potential therapeutic mediators within these EVs.

Main Methods:

  • Analysis of EVs produced during in vitro co-culture of T. cruzi (Tp) and DCs.
  • Characterization of EV size, morphology, and molecular markers (exosome markers, intracellular RNA).
  • Assessment of EV capture by unstimulated DCs and their effect on LPS-stimulated DCs.

Main Results:

  • T. cruzi trypomastigotes increased the number and size of EVs released by DCs.
  • EVs contained exosome markers and intracellular RNA, with altered protein profiles due to parasite interaction.
  • EVs from Tp-DC interaction were more readily captured by unstimulated DCs and modulated the activation of stimulated DCs.
  • Treatment with these EVs conferred protection against lethal T. cruzi infection in animal models.

Conclusions:

  • EVs derived from the T. cruzi-DC interaction exhibit unique characteristics and influence DC function.
  • These parasite-modified EVs demonstrate therapeutic potential for T. cruzi infections.
  • Further molecular characterization is needed to identify specific therapeutic mediators.

Related Concept Videos

Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.6K